Drug Topics

SEPTEMBER 30, 2023

As the Southern Hemisphere sees a mixed flu season, uncertainty looms for those in the North.

469

469

STAT

SEPTEMBER 30, 2023

Next week, 50 medical experts from the Karolinska Institutet in Stockholm will meet to award the 2023 Nobel Prize for Physiology or Medicine. The vote takes place on Oct. 2, but betting-minded scientists are already beginning to make their picks for who might take home the gold. Seasoned Nobel prognosticators will point out that the medicine prize often cycles between super-basic molecular biology and inventions that actually cure people.

145

145

The Checkup by Singlecare

SEPTEMBER 30, 2023

When you step into the cold medicine aisle at your local pharmacy, it’s crucial to take your time, especially if you have a history of hypertension (high blood pressure) or heart problems. Rushing in this aisle could lead to choosing a cold medicine that worsens your blood pressure or heart condition, including decongestants and medicine containing ibuprofen or naproxen.

Labelling 97

Labelling FDA 97

STAT

SEPTEMBER 30, 2023

In an unexpected turnabout, Johnson & Johnson announced it would not enforce any of its patents for a key tuberculosis medicine in 134 low- and middle-income countries, the second time in recent weeks that a manufacturer has agreed to widen access to products needed to combat the infectious disease. The move comes after the health care giant has recently faced accelerating demands to alter its pricing and patenting policies for the drug, which is called bedaquiline and is considered the back

144

144

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

Patient Care

The Checkup by Singlecare

SEPTEMBER 30, 2023

Bupropion ( Wellbutrin XL , Wellbutrin SR , Aplenzin , Forfivo XL ) is a norepinephrine-dopamine reuptake inhibitor (NDRI) that treats major depressive disorder , prevents seasonal affective disorder, and helps people stop smoking. Bupropion interacts with antidepressants, drugs that increase the risk of seizures, and drugs that increase dopamine. It also interacts with alcohol and caffeine.

Dosage 52

Dosage Communication FDA 52

PharmExec

SEPTEMBER 30, 2023

EXXUA has been approved for treatment.

FDA 52

FDA 52

PharmExec

SEPTEMBER 30, 2023

The company announced new hires for its chief scientific officer, chief business officer, and other leadership roles.

52

52